|

Understanding Cancer in Women: Why It Matters and What We Can Do

Understanding Cancer in Women: Why It Matters and What We Can Do

Lung cancer and mesothelioma are a big worry for women worldwide. Many things like our bodies, the environment, and how we live can make this disease more likely.

It’s the main cause of cancer deaths in women in some countries. But when we talk about lung cancer and mesothelioma, we often think more about men. This makes it hard to learn about, treat, and help women who have it.

A new study in Clinical Lung Cancer looks at the history and future of lung cancer in women.

Decoding Women’s Unique Risks

Researchers say it’s hard for women with lung cancer or mesothelioma to get the right help. Not enough women are part of studies to learn about cancer treatments. There aren’t clear rules for treating women with these types of cancer. And sometimes, doctors don’t think about how being a woman might affect treatments or how they feel after.

Women with cancer face many problems. They might feel sad or worried, and it’s tough to talk about these feelings with doctors. People might judge them because they had lung cancer, making life harder for them and their families.

Empowering Women in the Fight Against Lung Cancer

To help women with cancer, researchers say need to look at everything, like how their bodies work, the world around them, and how they live. We should include more women in studies about cancer treatments. Doctors need to think about how being a woman might change the best ways to treat cancer.

Mesothelioma is another kind of cancer that affects the lungs. It’s caused by being around asbestos, a material used in old buildings. Both lung cancer and mesothelioma can be caused by things in the air or our environment. That’s why learning about lung cancer in women can also help us understand and treat mesothelioma better.

Lung cancer and mesothelioma in women is a big problems, and many things cause it. To help them, we need to think about everything that might make it more likely for women to get lung cancer. By learning more about this and giving better care, we can find better ways to prevent, find, and treat lung cancer in women.

Source:

Florez, Narjust, Lauren Kiel, Ivy Riano, Shruti Patel, Kathryn DeCarli, Natasha Dhawan, Ivy Franco, et al. “Lung Cancer in Women: The Past, Present, and Future.” Clinical Lung Cancer 0, no. 0 (October 19, 2023). https://doi.org/10.1016/j.cllc.2023.10.007.

 

Similar Posts

  • |

    Mesothelioma Blood Test May Be Possible

    An international team of researchers is studying the proteins found on the surface of cancer cells in an effort to improve mesothelioma diagnosis. The team, made up of scientists from the US, Switzerland, Italy and Chile, has just published their findings on a new kind of test to identify protein-derived mesothelioma biomarkers in blood serum. Mesothelioma is an aggressive cancer of the membranes around organs. Because the most common mesothelioma biomarker, mesothelin, is also overproduced by other kinds of cancer cells, it has only limited diagnostic value. A test to identify a set of proteins produced specifically by mesothelioma cells could greatly improve diagnostic accuracy. Led by Ferdinando Cerciello and Bernd Wollscheid of the Institute of Molecular Systems Biology in…

  • | |

    Needle Biopsy “Simple, Safe & Accurate” for Mesothelioma

    Mesothelioma researchers in China say a biopsy method that involves a single skin puncture can produce good diagnostic results for mesothelioma patients with little pain or risk. The study focused on percutaneous (through the skin) biopsy in patients who had unexplained fluid buildup or swelling in their abdomens. Abdominal distension and fluid buildup (called ascites) can be signs of peritoneal mesothelioma, a rare but aggressive cancer of the abdominal lining caused by exposure to asbestos. Peritoneal mesothelioma accounts for less than 30% of all mesothelioma cases. Because the symptoms may be vague and often develop many decades after asbestos exposure, peritoneal mesothelioma can be especially challenging to diagnose.  Misdiagnosis and under-diagnosis are not uncommon. In the newest study on percutaneous…

  • | |

    Inflammation Both “Friend and Foe” in Mesothelioma

    An immune system response that causes mesothelioma symptoms such as fever, fatigue, and weight loss may also be helpful to clinicians as a way to find and treat the disease. Scientists with The Asbestos Diseases Research Institute in Sydney, Australia make that case that both systemic inflammation (throughout the body) and at the site of a tumor – has long been associated with mesothelioma and other cancers. Inflammation results when the body attempts to address the imbalances of cancer by producing more of certain immune system cells. Some inflammatory markers, such as CD+8 T-cells and C-reactive protein, have been linked to better prognosis in mesothelioma. Other inflammatory markers, such as certain macrophages and a high neutrophil-to-lymphocyte ratio, can signal the…

  • |

    New Prognostic Factor in Peritoneal Mesothelioma

    Malignant peritoneal mesothelioma is a rare form of mesothelioma that attacks the membrane that lines the abdomen and surrounds internal organs. The outlook for this rare malignancy, which affects fewer than 500 Americans annually, has been improved by the treatment combination of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). The combination has produced 5-year overall survival rates ranging from 29% to 63%. But not all peritoneal mesothelioma patients are good candidates for CRS/HIPEC. The challenge, for clinicians, is identifying which patients are likely to benefit from the procedure (or even be cured) and which are not. In an effort to help answer that question, French researchers recently tested the prognostic value of the glucose transporter protein GLUT1 as well as…

  • | |

    FDG PET-CT Results Could Lead to Improved Mesothelioma Treatment

    In a recent study, researchers say a better understanding of certain diagnostic criteria could result in more targeted treatments for malignant mesothelioma. In a recent published report, doctors from the medical school at Dicle University in Diyarbakir, Turkey measured the relationship between PET-CT scan results and survival in 177 patients with malignant pleural mesothelioma. The patients were diagnosed between April 2007 and April 2011. They had a mean age of 55.4 and most (56%) were male. Patients in the study all had FDG PET-CT scans before beginning their mesothelioma treatment. FDG PET-CT scanning is a powerful imaging tool for mesothelioma and other cancers that combines a radioactive tracer with a combination of positron emission tomography and computed tomography scanning.  Because…

  • | |

    Mesothelioma Surgeons Report New Biopsy Technique

    A team of surgeons in Maryland have demonstrated how using a standard biopsy tool in a new way could improve the biopsy process for certain mesothelioma patients. An aggressive cancer of the pleural lining around the lungs, malignant pleural mesothelioma usually requires a tissue biopsy to make a definitive diagnosis. Often this is done using a rigid tool called a thoracoscope inserted into the chest wall while the patient is under general anesthesia. However, mesothelioma doctors at Walter Reed National Military Medical Center detail the case of a 79-year-old suspected mesothelioma patient whose biopsy was done in a minimally-invasive way, under conscious sedation, thanks to the novel use of a standard tool. Although the patient had several of the common signs…